Using teledermoscopy and AI to improve skin cancer diagnosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the implementation of teledermoscopy in clinical practice to assess its impact on referral patterns, diagnostic accuracy, and the risk of undetected skin cancers. It consists of two parts: the first part evaluates the safety and effectiveness of teledermoscopy compared to conventional care, while the second part examines the integration of artificial intelligence algorithms to enhance diagnostic accuracy among teledermoscopic assessors. Data will be collected through teledermoscopic referrals, patient records, and questionnaires from both primary care and dermatology clinics. Statistical analyses will compare consultation rates and diagnostic outcomes before and after the introduction of teledermoscopy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Has a skin lesion assessed by a physician during a visit
* The physician decides to create a teledermoscopy referral

Exclusion Criteria:

* inability or unwillingness to participate in the study
* the patient is younger than 15 years old
* Images of such bad quality they cannot be assessed

Where it's running

• Department of dermatology, Skane University Hospital
  Lund, Sweden Recruiting

Study contacts

• Principal investigator: Asa Ingvar, PhD — Department of Dermatology, Skane University Hospital, Region Skane, Sweden
• Study coordinator: Asa Ingvar, PhD
• Email: asa.ingvar@skane.se
• Phone: +4646172243

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Mobile sun protection support to help young adults stay safe in the sun

  This project tests a mobile health program to see if reminders, education, planning tools, and real-time sun exposure information can help young adults protect their skin from excessive sun exposure.

  Recruiting University of Utah · Salt Lake City, Utah · NCT07830394

• Psycho-physiological profiling of people with low versus high heat resilience

  This project will test whether controlled heat and UV exposures plus physiological and psychological measurements can identify healthy adults who are more or less resilient to heat.

  Recruiting at 2 sites University of Thessaly · Copenhagen and 1 other locations · NCT07510061

• Cosibelimab for tough CSCC in kidney transplant recipients or blood cancers

  This trial tests cosibelimab in people with advanced cutaneous squamous cell carcinoma who have a kidney transplant or certain blood cancers to see if it is safe and helpful for them.

  Recruiting at 2 sites Phase 4 Dana-Farber Cancer Institute · Boston, Massachusetts and 1 other locations · NCT07426484

• First-line immunotherapy and PD-L1 testing for metastatic melanoma in Slovenia

  This study will see if first-line immunotherapy (pembrolizumab, nivolumab, or ipilimumab plus nivolumab) works for adults in Slovenia with metastatic melanoma and whether PD-L1 measurements predict who responds.

  Recruiting Institute of Oncology Ljubljana · Ljubljana · NCT07422779

• Optical and multi-modal analysis to help diagnose skin cancer

  This project tests whether combining optical spectroscopy and imaging data from skin samples can help diagnose skin cancer in people with skin concerns.

  Recruiting Centre Hospitalier Régional Metz-Thionville · Metz · NCT07406022

• Early skin tumor detection with telemedicine in primary care

  This project will test whether a telemedicine tool used by general practitioners can help detect suspicious skin lesions earlier in people with fair skin in the Czech Republic.

  Recruiting at 2 sites Institute of Health Information and Statistics of the Czech Republic · Brno and 4 other locations · NCT07349940

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.